ClinicalTrials.gg
TerminatedNCT03322150Updated Mar 14, 2019

Effect of Atropine or Glycopyrrolate on the Prevention of Bradycardia During Sedation Using Dexmedetomidine in Adult Patients Undergoing Lower Extremity Surgery Under Spinal Anesthesia

An interventional study of Atropine and Glycopyrrolate in Spinal Anesthesia, sponsored by Yonsei University. Terminated at 1 site in Korea, Republic of. Open to participants aged 20 Years to 60 Years. Per ClinicalTrials.gov, last updated 2019-03-14.

Sponsored by Yonsei University · Not applicable, Interventional, and Prevention

Why this study was terminated
The research was terminated because the recruitment of the study subjects was not smooth and the overseas training of the investigator was scheduled.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
2
Allocation
Randomized
Ages
20 Years to 60 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-17

Among 12 studies in Bradycardia with a site in Korea, Republic of — 4 open to participants now, 4 under way, none of them phase 3. Bradycardia · Korea, Republic of.

Started
2017
with 2 others
No phase
5 of 12
3 open now
Registered
5th of 12
by date
Lead sponsor
4 of 12
Yonsei University

Among the 12 studies in Bradycardia with a site in Korea, Republic of, this one is one of 3 that started in 2017, is one of 5 with no phase, and was the 5th registered.

Bradycardia

317 studies on the registry are indexed under Bradycardia; 71 are open to participants now.

Browse Bradycardia studies →

Open to participants now

4 of the 12 studies in Bradycardia with a site in Korea, Republic of are open now. Recruiting first, the newest first:

All 4 open studies →

A study can be open while its sites in Korea, Republic of have not opened yet or have stopped. Only those recruiting at a site in Korea, Republic of →

Who these studies take

Of the 51 Bradycardia studies recruiting now, 34 (67%) set no upper age limit and 9 (18%) stop at 75 or younger; 4 take children under 18; 4 take healthy volunteers.

This study: 20 Years to 60 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 12 studies in Bradycardia with a site in Korea, Republic of, or all of them as a file.
02

Study summary

Patients undergoing lower extremity surgery with spinal anesthesia are often sedated to reduce patient discomfort due to large noises during surgery and also to reduce anxiety. Most commonly used sedatives include propofol and midazolam, but these agents are known to often cause hypotension or respiratory depression. Dexmedetomidine is a selective alpha 2 adrenergic drug, which acts as a sedative and also has analgesia effects. In contrast to propofol or midazolam, dexmedetomidine rarely causes respiratory depression, and therefore is often used in critically ill patients in the ICU and also in patients undergoing simple procedures. Hemodynamically, dexmedetomidine evokes a biphasic blood pressure response with a short hypertensive phase and subsequent hypotension. Bradycardia is also observed in many patients, which may lead to more serious outcomes when progressing to sinus pause or shock. Therefore, drugs to prevent bradycardia during dexmedetomidine infusion may help patients maintain a more stable hemodynamic state. The present study aims to compare the ability of atropine and glycopyrrolate to prevent bradycardia during dexmedetomidine infusion in patients undergoing lower extremity orthopedic surgery with spinal anesthesia.

03

Conditions studied

  • Spinal Anesthesia

Browse trials for

Keywords

  • Atropine
  • glycopyrrolate
  • bradycardia
  • dexmedetomidine
  • spinal anesthesia
04

Who can participate

Ages eligible
20 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Patients 65 years or older undergoing total knee replacement surgery under spinal anesthesia.
  2. 1-3

Exclusion criteria

Exclusion Criteria:

  1. Patients with coagulation abnormalities
  2. End organ diseases of liver, lung or kidney
  3. Severe aortic stenosis
  4. High degree AV block
  5. Heart failure
  6. Patients on MAO inhibitors
  7. History of seizures or epilepsy
  8. Glaucoma
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
2 participants (actual)

Study arms

  • Active comparator
    Atropine group

    Patients that receive atropine 0.01 mg/kg (max 0.5mg) before spinal anesthesia

    Drug: Atropine

  • Active comparator
    Glycopyrrolate group

    Patients that receive glycopyrrolate 0.004mg/kg (max 0.2 mg) before spinal anesthesia

    Drug: Glycopyrrolate

Interventions

  • Atropine injection (0.01 mg/kg, max 0.5 mg) 3 minutes before spinal anesthesia

  • Glycopyrrolate (0.00 4mg/kg, max 0.2 mg) 3 minutes before spinal anesthesia

06

What researchers measure

Primary outcomes

  1. Pulse rate

    measured as beats per minute, heart rate below 60 bpm or decrease of more than 30% from baseline is defined as bradycardia.

    Time frame: From 5 minutes before spinal anesthesia~end of surgery (Intraoperatively)

  2. blood pressure

    measured as mmHg, mean blood pressure lower than 60 mmHg or decrease of more than 30% from baseline is defined as hypotension.

    Time frame: From 5 minutes before spinal anesthesia~end of surgery (Intraoperatively)

07

Study locations

1 site
  • Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institute, Yonsei University College of Medicine
    Seoul, 03722, Korea, Republic of
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Oct 2017 to primary completion in Aug 2018, 10 months.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 23, 2017
First posted
Oct 26, 2017
StartActual
Oct 1, 2017
Primary completionActual
Aug 1, 2018
CompletionActual
Aug 1, 2018
Last update
Mar 14, 2019
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 14, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03322150
Lead sponsor
Yonsei University
Responsible party
Sponsor
First posted
Oct 26, 2017
Start date
Oct 1, 2017
Primary completion
Aug 1, 2018
Completion
Aug 1, 2018
Last update
Mar 14, 2019

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Mar 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drugs tested here: Atropine · Glycopyrrolate

Start the discussion